Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance

Diamyd Medical has reached alignment with the U.S. Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its ongoing pivotal, registrational Phase 3 DIAGNODE-3 trial in type ...

"DON'T TOUCH THEM, MOVE THEM, OR EVEN THINK ABOUT KEEPING A NEW SHELF ORNAMENT": Some People Were Suuuuuuper Lucky That The Internet Stepped Up …

DO NOT ASSUME UXOs ARE SAFE TO HANDLE. DON'T TOUCH THEM, MOVE THEM, OR EVEN THINK ABOUT KEEPING A NEW SHELF ORNAMENT. (I wish ...
Trains on MSN

Four Feather Falls: Rediscovering Lone Star Treble-O-lectric

I first encountered the Lone Star Treble-O-lectric system when one of my old school friends had a box full of play-worn ...
Scientific Research Publishing

Multimodal Digital Phenotyping for Bipolar Disorder: Robust Mood-State Classification and Early Relapse Risk Monitoring ()

Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...

Tech ETF Faceoff: FTEC Vs. XLK (The Winner May Surprise You)

As you can see from the graphic, over the past five years, XLK has outperformed FTEC by 8.6%. Apparently, that is enough for ...